They also provided experimental evidence for the mechanism by which MIAT influences the progression of BRCA, showing that MIAT overexpressed in breast cancer cells promotes invasion, migration, and DLG3 promoter methylation. This evidence concerns the gene DLG3 and breast carcinoma.